Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study Angelos G. Vilos, MD, George A. Vilos, MD, Jackie Hollett-Caines, MD, Greg Garvin, MD, Roman Kozak, MB BS, Basim Abu-Rafea, MD Journal of Obstetrics and Gynaecology Canada Volume 36, Issue 11, Pages 983-989 (November 2014) DOI: 10.1016/S1701-2163(15)30411-4 Copyright © 2014 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Figure 1 Mean (± SD) dose of morphine used per hour (0 to 19mg), as delivered by patient controlled anaesthesia pump following uterine artery embolization with either Gelfoam alone (n=8) or Gelfoam+Embospheres (n=9) as occlusion material Journal of Obstetrics and Gynaecology Canada 2014 36, 983-989DOI: (10.1016/S1701-2163(15)30411-4) Copyright © 2014 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Figure 2 Median (Q1, Q3) uterine volume (cm3) of women at baseline and at 3, 6, and 12months of follow-up after uterine artery embolization with either Gelfoam alone or Gelfoam+Embospheres as occlusion material Journal of Obstetrics and Gynaecology Canada 2014 36, 983-989DOI: (10.1016/S1701-2163(15)30411-4) Copyright © 2014 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Figure 3 Median (Q1, Q3) dominant fibroid volume (cm3) of women at baseline and at 3, 6, and 12months of follow-up after uterine artery embolization with either Gelfoam alone or Gelfoam+Embospheres as occlusion material Journal of Obstetrics and Gynaecology Canada 2014 36, 983-989DOI: (10.1016/S1701-2163(15)30411-4) Copyright © 2014 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions